190 related articles for article (PubMed ID: 32442424)
21. Structure-activity relationship of uridine-based nucleoside phosphoramidate prodrugs for inhibition of dengue virus RNA-dependent RNA polymerase.
Wang G; Lim SP; Chen YL; Hunziker J; Rao R; Gu F; Seh CC; Ghafar NA; Xu H; Chan K; Lin X; Saunders OL; Fenaux M; Zhong W; Shi PY; Yokokawa F
Bioorg Med Chem Lett; 2018 Jul; 28(13):2324-2327. PubMed ID: 29801997
[TBL] [Abstract][Full Text] [Related]
22. GSK983: a novel compound with broad-spectrum antiviral activity.
Harvey R; Brown K; Zhang Q; Gartland M; Walton L; Talarico C; Lawrence W; Selleseth D; Coffield N; Leary J; Moniri K; Singer S; Strum J; Gudmundsson K; Biron K; Romines KR; Sethna P
Antiviral Res; 2009 Apr; 82(1):1-11. PubMed ID: 19187793
[TBL] [Abstract][Full Text] [Related]
23. The discovery of IDX21437: Design, synthesis and antiviral evaluation of 2'-α-chloro-2'-β-C-methyl branched uridine pronucleotides as potent liver-targeted HCV polymerase inhibitors.
Alexandre FR; Badaroux E; Bilello JP; Bot S; Bouisset T; Brandt G; Cappelle S; Chapron C; Chaves D; Convard T; Counor C; Da Costa D; Dukhan D; Gay M; Gosselin G; Griffon JF; Gupta K; Hernandez-Santiago B; La Colla M; Lioure MP; Milhau J; Paparin JL; Peyronnet J; Parsy C; Pierra Rouvière C; Rahali H; Rahali R; Salanson A; Seifer M; Serra I; Standring D; Surleraux D; Dousson CB
Bioorg Med Chem Lett; 2017 Sep; 27(18):4323-4330. PubMed ID: 28835346
[TBL] [Abstract][Full Text] [Related]
24. Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitors.
Mish MR; Cho A; Kirschberg T; Xu J; Zonte CS; Fenaux M; Park Y; Babusis D; Feng JY; Ray AS; Kim CU
Bioorg Med Chem Lett; 2014 Jul; 24(14):3092-5. PubMed ID: 24907145
[TBL] [Abstract][Full Text] [Related]
25. RNA-Dependent RNA Polymerase as a Target for COVID-19 Drug Discovery.
Zhu W; Chen CZ; Gorshkov K; Xu M; Lo DC; Zheng W
SLAS Discov; 2020 Dec; 25(10):1141-1151. PubMed ID: 32660307
[TBL] [Abstract][Full Text] [Related]
26. Two RNA Tunnel Inhibitors Bind in Highly Conserved Sites in Dengue Virus NS5 Polymerase: Structural and Functional Studies.
Arora R; Liew CW; Soh TS; Otoo DA; Seh CC; Yue K; Nilar S; Wang G; Yokokawa F; Noble CG; Chen YL; Shi PY; Lescar J; Smith TM; Benson TE; Lim SP
J Virol; 2020 Nov; 94(24):. PubMed ID: 32907977
[TBL] [Abstract][Full Text] [Related]
27. Discovery of Potent Non-nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from Fragment Screening and Structure-Guided Design.
Lim SP; Noble CG; Nilar S; Shi PY; Yokokawa F
Adv Exp Med Biol; 2018; 1062():187-198. PubMed ID: 29845534
[TBL] [Abstract][Full Text] [Related]
28. Structure-activity relationship of a pyrimidine receptor in the rat isolated superior cervical ganglion.
Connolly GP; Harrison PJ
Br J Pharmacol; 1995 Nov; 116(6):2764-70. PubMed ID: 8591002
[TBL] [Abstract][Full Text] [Related]
29. Cordycepin Inhibits Virus Replication in Dengue Virus-Infected Vero Cells.
Panya A; Songprakhon P; Panwong S; Jantakee K; Kaewkod T; Tragoolpua Y; Sawasdee N; Lee VS; Nimmanpipug P; Yenchitsomanus PT
Molecules; 2021 May; 26(11):. PubMed ID: 34071102
[TBL] [Abstract][Full Text] [Related]
30. Assessment of drug candidates for broad-spectrum antiviral therapy targeting cellular pyrimidine biosynthesis.
Marschall M; Niemann I; Kosulin K; Bootz A; Wagner S; Dobner T; Herz T; Kramer B; Leban J; Vitt D; Stamminger T; Hutterer C; Strobl S
Antiviral Res; 2013 Dec; 100(3):640-8. PubMed ID: 24149002
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of RNA binding to hepatitis C virus RNA-dependent RNA polymerase: a new mechanism for antiviral intervention.
Ahmed-Belkacem A; Guichou JF; Brillet R; Ahnou N; Hernandez E; Pallier C; Pawlotsky JM
Nucleic Acids Res; 2014 Aug; 42(14):9399-409. PubMed ID: 25053847
[TBL] [Abstract][Full Text] [Related]
32. Protein-protein interactions by influenza polymerase subunits as drug targets.
Felicetti T; Massari S
Future Med Chem; 2022 Jan; 14(2):53-56. PubMed ID: 34730024
[No Abstract] [Full Text] [Related]
33. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir.
Yin W; Mao C; Luan X; Shen DD; Shen Q; Su H; Wang X; Zhou F; Zhao W; Gao M; Chang S; Xie YC; Tian G; Jiang HW; Tao SC; Shen J; Jiang Y; Jiang H; Xu Y; Zhang S; Zhang Y; Xu HE
Science; 2020 Jun; 368(6498):1499-1504. PubMed ID: 32358203
[TBL] [Abstract][Full Text] [Related]
34. Antiviral activity of A771726, the active metabolite of leflunomide, against Junín virus.
Sepúlveda CS; García CC; Damonte EB
J Med Virol; 2018 May; 90(5):819-827. PubMed ID: 29315647
[TBL] [Abstract][Full Text] [Related]
35. 2-(3-Thienyl)-5,6-dihydroxypyrimidine-4-carboxylic acids as inhibitors of HCV NS5B RdRp.
Pacini B; Avolio S; Ercolani C; Koch U; Migliaccio G; Narjes F; Pacini L; Tomei L; Harper S
Bioorg Med Chem Lett; 2009 Nov; 19(21):6245-9. PubMed ID: 19800789
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of vaccinia virus replication by N-(phosphonoacetyl)-L-aspartate: differential effects on viral gene expression result from a reduced pyrimidine nucleotide pool.
Katsafanas GC; Grem JL; Blough HA; Moss B
Virology; 1997 Sep; 236(1):177-87. PubMed ID: 9299630
[TBL] [Abstract][Full Text] [Related]
37. Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase.
Howe AY; Bloom J; Baldick CJ; Benetatos CA; Cheng H; Christensen JS; Chunduru SK; Coburn GA; Feld B; Gopalsamy A; Gorczyca WP; Herrmann S; Johann S; Jiang X; Kimberland ML; Krisnamurthy G; Olson M; Orlowski M; Swanberg S; Thompson I; Thorn M; Del Vecchio A; Young DC; van Zeijl M; Ellingboe JW; Upeslacis J; Collett M; Mansour TS; O'Connell JF
Antimicrob Agents Chemother; 2004 Dec; 48(12):4813-21. PubMed ID: 15561861
[TBL] [Abstract][Full Text] [Related]
38. Anti-hepatitis C virus activity of novel beta-d-2'-C-methyl-4'-azido pyrimidine nucleoside phosphoramidate prodrugs.
Rondla R; Coats SJ; McBrayer TR; Grier J; Johns M; Tharnish PM; Whitaker T; Zhou L; Schinazi RF
Antivir Chem Chemother; 2009 Oct; 20(2):99-106. PubMed ID: 19843980
[TBL] [Abstract][Full Text] [Related]
39. Severe cytochrome c oxidase inhibition in vivo does not induce a pyrimidine deficiency; neuroprotective action of oral uridine prodrug PN401 requires supraphysiological levels of uridine.
Garcia RA; Liu L; Hu Z; Gonzalez A; von Borstel RW; Saydoff JA
Brain Res; 2005 Dec; 1066(1-2):164-71. PubMed ID: 16330000
[TBL] [Abstract][Full Text] [Related]
40. Cyanorona-20: The first potent anti-SARS-CoV-2 agent.
Rabie AM
Int Immunopharmacol; 2021 Sep; 98():107831. PubMed ID: 34247016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]